| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |